A detailed history of Armstrong Advisory Group, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 363 shares of MRNA stock, worth $13,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
363
Previous 263 38.02%
Holding current value
$13,376
Previous $31,000 22.58%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$63.64 - $125.14 $6,364 - $12,514
100 Added 38.02%
363 $24,000
Q2 2024

Jul 12, 2024

BUY
$101.21 - $166.61 $5,161 - $8,497
51 Added 24.06%
263 $31,000
Q4 2022

Jan 17, 2023

BUY
$118.38 - $210.04 $25,096 - $44,528
212 New
212 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.